Complete Filing Data
Thayer Ventures Acquisition Corp II reported Stockholders Equity of -$8.18 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Thayer Ventures Acquisition Corp II did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | $3.9M |
| Other Nonoperating Income Expense | $4.9M |
| Operating Income Loss | -$1.0M |
| General And Administrative Expense | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Net Income Loss | $2.0M | $490.7K | -$163.1K | -$14.3K | -$24.6K |
| Other Nonoperating Income Expense | $2.1M | $962.3K | -$145.0K | $0.00 | $0.00 |
| Operating Income Loss | -$158.1K | -$471.6K | -$18.1K | -$14.3K | -$24.6K |
| General And Administrative Expense | $158.1K | $471.6K | $18.1K | $14.3K | $24.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$8.2M | -$39.4K |
| Retained Earnings Accumulated Deficit | -$8.2M | -$64.4K |
| Preferred Stock Value | $0.00 | $0.00 |
| Notes Payable Current | $10.00 | $60.4K |
| Liabilities Current | $155.5K | $662.2K |
| Liabilities And Stockholders Equity | $206.8M | $622.8K |
| Liabilities | $8.6M | $662.2K |
| Deferred Legal Fees | $920.1K | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $258.0K | $0.00 |
| Assets | $206.8M | $622.8K |
| Accrued Offering Costs | $128.1K | $575.9K |
| Deferred Offering Costs Included In Accrued Offering Costs | $0.00 | |
| Temporary Equity Carrying Amount Attributable To Parent | $206.4M | $0.00 |
| Other Liabilities Current | $1.3K | $0.00 |
| Deferred Underwriting Fee Payable | $7.6M | $0.00 |
| Deferred Offering Costs Non Current | $0.00 | $622.8K |
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | $40.0K | |
| Assets Held In Trust Noncurrent | $206.4M | $0.00 |
| Assets Current | $436.9K | $0.00 |
| Accounts Payable And Accrued Liabilities Current | $26.1K | $25.9K |
| Deferred Offering Costs Included In Deferred Legal Fees | $751.4K | |
| Other Receivables Net Current | ||
| Deferred Oferring Cost Paid By Related Party | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $258.0K | |
| Deferred Fees | $168.7K | |
| Deferred Offering Costs In Accrued Liabilities | $244.3K | |
| Deferred Offering Costs | ||
| Accrued Liabilities Current |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$7.8M | -$7.6M | -$57.5K | -$13.9K | $353.00 | |
| Retained Earnings Accumulated Deficit | -$7.8M | -$7.6M | -$227.5K | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | |||
| Notes Payable Current | $10.00 | $10.00 | $158.9K | |||
| Liabilities Current | $125.0K | $142.1K | $747.6K | |||
| Liabilities And Stockholders Equity | $205.1M | $203.1M | $1.1M | |||
| Liabilities | $8.5M | $8.5M | $1.2M | |||
| Deferred Legal Fees | $811.4K | $811.4K | $450.1K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 | $0.00 | |||
| Assets | $205.1M | $203.1M | $1.1M | |||
| Accrued Offering Costs | $71.4K | $79.4K | $572.7K | |||
| Deferred Offering Costs Included In Accrued Offering Costs | $27.3K | $4.9K | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $204.4M | $202.2M | ||||
| Other Liabilities Current | $1.3K | $1.3K | ||||
| Deferred Underwriting Fee Payable | $7.6M | $7.6M | ||||
| Deferred Offering Costs Non Current | $0.00 | $0.00 | ||||
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | $40.0K | |||||
| Assets Held In Trust Noncurrent | $204.4M | $202.2M | ||||
| Assets Current | $647.9K | $779.3K | ||||
| Accounts Payable And Accrued Liabilities Current | $52.2K | $61.3K | ||||
| Deferred Offering Costs Included In Deferred Legal Fees | $450.1K | |||||
| Other Receivables Net Current | $461.4K | $603.9K | $0.00 | |||
| Deferred Oferring Cost Paid By Related Party | $228.2K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $0.00 | |||||
| Deferred Fees | ||||||
| Deferred Offering Costs In Accrued Liabilities | ||||||
| Deferred Offering Costs | $1.1M | $622.8K | ||||
| Accrued Liabilities Current | $16.0K | $25.9K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Share Based Compensation | $181.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $18.2K |
| Net Cash Provided By Used In Operating Activities | $617.1K |
| Proceeds From Repayments Of Related Party Debt | -$1.7M |
| Proceeds From Issuance Of Private Placement | $3.6M |
| Proceeds From Issuance Of Medium Term Notes | -$158.9K |
| Proceeds From Issuance Of Common Stock | $197.8M |
| Payments Of Issuance Costs | $661.7K |
| Payments For Proceeds From Investments | $201.3M |
| Net Cash Provided By Used In Investing Activities | -$201.3M |
| Increase Decrease In Prepaid Expense | $202.7K |
| Increase Decrease In Due To Related Parties Current | $1.3K |
| Increase Decrease In Due From Related Parties Current | -$1.7M |
| Increase Decrease In Accrued Liabilities | |
| Net Cash Provided By Financing Activities | $200.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Share Based Compensation | $0.00 | $36.3K | $145.0K | $0.00 | $0.00 |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.6K | ||||
| Net Cash Provided By Used In Operating Activities | $0.00 | ||||
| Proceeds From Repayments Of Related Party Debt | |||||
| Proceeds From Issuance Of Private Placement | |||||
| Proceeds From Issuance Of Medium Term Notes | |||||
| Proceeds From Issuance Of Common Stock | |||||
| Payments Of Issuance Costs | |||||
| Payments For Proceeds From Investments | |||||
| Net Cash Provided By Used In Investing Activities | |||||
| Increase Decrease In Prepaid Expense | |||||
| Increase Decrease In Due To Related Parties Current | |||||
| Increase Decrease In Due From Related Parties Current | |||||
| Increase Decrease In Accrued Liabilities | $8.1K | ||||
| Net Cash Provided By Financing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Temporary Equity Shares Issued | 20.1M | |
| Weighted Average Number Of Diluted Shares Outstanding |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Temporary Equity Shares Issued | 20.1M | 20.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 875.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Gross Investment Income Operating | $5.1M | |
| Additional Paid In Capital | $0.00 | $24.3K |
| Other Noncash Expense | $10.0K | |
| Prepaid Insurance Non Current | $23.8K | $0.00 |
| Prepaid Expense Current | $178.9K | $0.00 |
| Formation Cost In Exchange Of Issuance Of Ordinary Shares | 0.00 | |
| Adjustments To Additional Paid In Capital Mark To Market | $4.0M | |
| Prepaid Service Contributed By Related Party | ||
| Adjustments To Additional Paid In Capital Accretion To Redemption Amount | $19.6M | |
| Value Of Private Placement Of Units Sold | $3.6M | |
| Stock Issued During Period Value New Issues | ||
| Paymentofundewriterreimbursement | $2.0M | |
| Netcashprovidedbyfinancingactivities | $200.9M | |
| Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs | -$243.3K | |
| Under Writers Over Allotment Option Exercised Units | $2.6M | |
| Stock Issued During Period Shares New Issues | 20.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Gross Investment Income Operating | $2.1M | $998.6K | $0.00 | $0.00 | |
| Additional Paid In Capital | $0.00 | $0.00 | $169.3K | ||
| Other Noncash Expense | $10.0K | $10.0K | |||
| Prepaid Insurance Non Current | $67.7K | $111.5K | |||
| Prepaid Expense Current | $186.5K | $175.4K | |||
| Formation Cost In Exchange Of Issuance Of Ordinary Shares | 13.1K | ||||
| Adjustments To Additional Paid In Capital Mark To Market | $4.0M | ||||
| Prepaid Service Contributed By Related Party | $7.0K | ||||
| Adjustments To Additional Paid In Capital Accretion To Redemption Amount | $2.1M | $15.5M | |||
| Value Of Private Placement Of Units Sold | $3.6M | ||||
| Stock Issued During Period Value New Issues | $25.0K | ||||
| Paymentofundewriterreimbursement | |||||
| Netcashprovidedbyfinancingactivities | |||||
| Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs | -$243.3K | ||||
| Under Writers Over Allotment Option Exercised Units | |||||
| Stock Issued During Period Shares New Issues |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.